Thomas Catinazzo
CIK: 0001818261
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Relay Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Oct 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $18.62$27K - Oct 6, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.5K shares at avg. $18.58$325K - Oct 6, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct206 shares at avg. $19.26$4K - Sep 8, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $18.94$336K - Aug 14, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $19.74$350K - Jul 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $18.61$27K - Jul 6, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $18.69$331K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $17.01$301K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct51.6K shares at avg. $16.97$875K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Exercise(M)Direct51.6K shares at avg. $4.45$229K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct61.6K shares at avg. $16.97$1.0M - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Exercise(M)Direct61.6K shares at avg. $5.22$321K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct56.3K shares at avg. $16.97$956K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Exercise(M)Direct56.3K shares at avg. $5.04$284K - May 14, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $12.86$228K - Apr 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct972 shares at avg. $14.79$14K - Apr 9, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $15.00$27K - Apr 9, 2026RLAY
Relay Therapeutics, Inc.
Exercise(M)Direct1.8K shares at avg. $5.22$9K - Apr 7, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $13.01$230K - Mar 9, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.7K shares at avg. $10.06$178K - Jan 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $8.45$14K - Jan 27, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct13.8K shares at avg. $7.62$105K - Jan 13, 2026RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
400K shares- - Oct 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct21.7K shares at avg. $7.29$158K - Jul 29, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct18.4K shares at avg. $3.68$68K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,469 | $18.62 | $27,353 | Direct |
| Oct 6, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,511 | $18.58 | $325,354 | Direct |
| Oct 6, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 206 | $19.26 | $3,968 | Direct |
| Sep 8, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $18.94 | $335,560 | Direct |
| Aug 14, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $19.74 | $349,734 | Direct |
| Jul 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,459 | $18.61 | $27,152 | Direct |
| Jul 6, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $18.69 | $331,131 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $17.01 | $301,366 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 51,560 | $16.97 | $874,973 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Exercise(M) | 51,560 | $4.45 | $229,442 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 61,563 | $16.97 | $1,044,724 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Exercise(M) | 61,563 | $5.22 | $321,359 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 56,323 | $16.97 | $955,801 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Exercise(M) | 56,323 | $5.04 | $283,868 | Direct |
| May 14, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $12.86 | $227,841 | Direct |
| Apr 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 972 | $14.79 | $14,376 | Direct |
| Apr 9, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,800 | $15.00 | $27,000 | Direct |
| Apr 9, 2026 | RLAY Relay Therapeutics, Inc. | Exercise(M) | 1,800 | $5.22 | $9,396 | Direct |
| Apr 7, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $13.01 | $230,498 | Direct |
| Mar 9, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,717 | $10.06 | $178,233 | Direct |
| Jan 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,695 | $8.45 | $14,323 | Direct |
| Jan 27, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 13,820 | $7.62 | $105,308 | Direct |
| Jan 13, 2026 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 21,664 | $7.29 | $157,931 | Direct |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 18,380 | $3.68 | $67,638 | Direct |
1-25 of 45 transactions
About Catinazzo Thomas
Catinazzo Thomas (SEC CIK 0001818261) files insider reports with the SEC as Chief Financial Officer of Relay Therapeutics, Inc. (RLAY).
Signal8 holds 22 ownership filings by Catinazzo Thomas, all Form 4s, filed between Oct 1, 2024 and Oct 30, 2026. Those filings report 45 transactions, from Sep 27, 2024 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Catinazzo Thomas's filings is in CAMBRIDGE, MA.
Recent filings by Catinazzo Thomas
- Oct 28, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Oct 6, 2026: Open-market sales of RLAY shares (2 lines, Form 4, code S).
- Sep 8, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Aug 14, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jul 28, 2026: Open-market sale of RLAY shares (Form 4, code S).
Other insiders filing for Relay Therapeutics, Inc. (RLAY)
- Rahmer Peter
- Bergstrom Donald A, President, R&D
- Patel Sanjiv, President and CEO
- SVF Pauling (Cayman) Ltd, 10% Owner
- Mazumdar Claire, Director
- Dable Habib J, Director